Keyphrases
Cholangiocarcinoma
100%
Protein Kinase CK2
57%
Liver
57%
Tumor
57%
Malignant Phenotype
57%
Metabolic Complexity
57%
Tumor Immunotherapy
57%
Cholangiocarcinoma Cells
57%
Breast Cancer
57%
Cancer Causes
57%
Estrogen Receptor 1 (ESR1)
57%
Tumor Microenvironment
57%
Alpha Expressions
57%
Primary Liver Cancer
57%
Metabolism
57%
Metabolic Homeostasis
28%
Promising Biomarkers
28%
Early Diagnosis
28%
Metabolic Pathway
28%
Lipid Acids
28%
Amino Acid Uptake
28%
Late Diagnosis
28%
Current Therapies
28%
Tumor Stroma
28%
Liver Disease
28%
Hepatocellular Carcinoma
28%
Clinical Significance
28%
Circulating Metabolites
28%
Hepatocellular Cholangiocarcinoma
28%
Diagnostic Biomarker
28%
High Mortality Rate
28%
Clinical Value
28%
Whole-body Metabolism
28%
Dysregulation
28%
Therapeutic Target
28%
Metabolic
28%
Systems Biology Approach
28%
Early Prognosis
28%
Prognostic Biomarker
28%
Cancer Mortality
28%
Estrogen
21%
Medicine and Dentistry
Neoplasm
85%
Cholangiocarcinoma
85%
Cancer Immunotherapy
57%
Liver Cancer
57%
Tumor Microenvironment
57%
Biological Marker
57%
Metabolism
28%
Liver Disease
28%
Mortality Rate
28%
Homeostasis
28%
Diagnosis
28%
Epithelioma
28%
Hepatocellular Carcinoma
28%
Amino Acid
28%
Early Diagnosis
28%
Metabolite
28%
Malignant Neoplasm
28%
Stroma
28%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor Alpha
57%
Metabolic Pathway
57%
